Consolidated Balance Sheet

Cash and cash equivalents

1,338.3

980.8

Current financial assets

1,316.6

2,410.5

Trade accounts receivable

2,268.1

2,021.4

Inventories

1,656.0

1,474.2

Other current assets

529.6

360.7

Income tax receivables

205.0

109.8

Assets held for sale

–

27.1

7,313.6

7,384.5

Intangible assets

11,531.0

9,867.2

Property, plant and equipment

2,861.6

2,647.2

Non-current financial assets

89.9

77.8

Other non-current assets

71.6

105.5

Deferred tax assets

853.8

736.4

15,407.9

13,434.1

Total assets

22,721.5

20,818.6

Current financial liabilities

2,015.2

440.4

Trade accounts payable

1,370.3

1,364.1

Other current liabilities

875.7

1,134.5

Income tax liabilities

626.5

465.1

Current provisions

939.8

494.7

Liabilities directly related to assets held for sale

–

–

5,827.5

3,898.8

Non-current financial liabilities

2,161.2

3,257.5

Other non-current liabilities

10.0

5.6

Non-current provisions

581.1

1,011.1

Provisions for pensions and other post-employment benefits

1,377.5

910.9

Deferred tax liabilities

979.1

665.5

5,108.9

5,850.6

Equity capital

565.2

565.2

Reserves

9,548.4

9,341.1

Gains/losses recognized immediately in equity

1,615.3

1,113.7

Equity attributable to Merck KGaA shareholders

11,728.9

11,020.0

Non-controlling interests

56.3

49.2

11,785.2

11,069.2

Total liabilities and equity

22,721.5

20,818.6